Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;116(3):170-172.
doi: 10.1016/j.acvd.2022.12.005. Epub 2023 Jan 20.

Clinical usefulness of admission versus monitoring troponin in patients with coronavirus disease 2019

Affiliations

Clinical usefulness of admission versus monitoring troponin in patients with coronavirus disease 2019

Agathe Beauvais et al. Arch Cardiovasc Dis. 2023 Mar.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The association between the concentration of high-sensitivity cardiac troponin (Hs-cTnI) and outcome at admission and during hospitalization. A. Survival curves of patients with coronavirus disease 2019 (COVID-19), stratified to the concentration of Hs-cTnI at admission, defined as either positive (blue line) if the concentration of Hs-cTnI was above the hospital's upper limit of normal, according to sex, or negative (red line). B. Odds ratios (ORs) and 95% confidence interval (CIs) for death according to the concentration of Hs-cTnI at admission (terciles above normal value). C. Temporal trend of concentration of Hs-cTnI among survivors (blue line) and deceased patients (red line) with COVID-19. D. Temporal trend of concentration of Hs-cTnI in patients with COVID-19, according to their hospitalization ward: patients admitted to an intensive care unit (ICU) directly from the emergency department (green line); patients admitted secondarily to an ICU after initial hospitalization in a medical ward (red line); and patients solely admitted to a medical ward throughout hospitalization (blue line).

References

    1. Smadja D.M., Mentzer S.J., Fontenay M., Laffan M.A., Ackermann M., Helms J., et al. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects. Angiogenesis. 2021;24:755–788. - PMC - PubMed
    1. Guo T., Fan Y., Chen M., Wu X., Zhang L., He T., et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:811–818. - PMC - PubMed
    1. Goudot G., Chocron R., Augy J.L., Gendron N., Khider L., Debuc B., et al. Predictive factor for COVID-19 worsening: insights for high-sensitivity troponin and D-Dimer and correlation with right ventricular afterload. Front Med (Lausanne) 2020;7:586307. - PMC - PubMed
    1. Majure D.T., Gruberg L., Saba S.G., Kvasnovsky C., Hirsch J.S., Jauhar R., et al. Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury. Am J Cardiol. 2021;138:100–106. - PMC - PubMed
    1. Bonnet G., Weizman O., Trimaille A., Pommier T., Cellier J., Geneste L., et al. Characteristics and outcomes of patients hospitalized for COVID-19 in France: the critical COVID-19 France (CCF) study. Arch Cardiovasc Dis. 2021;114:352–363. - PMC - PubMed